RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:I get the sense many are expecting a sudden popMafortuna, I slightly agree with you. Next Q, after this one to be released, will include the full financials of the last two acquisitions. However, you claim that an additional 15 M will give PHM an organic growth rate of 10%, it's actually more complicated than that.... It's half a year, so right off the bat you need to multiply by two, which makes the growth rate double. Also, it will only give patient Aids 4 months of time with the parent company so you need to discount it's ability to contribute to Phm's financials.
My thought is that if they don't buy anymore companies (highly unlikely), they'll end the 2015 calendar year with 158Mish run rate. I came to this by breaking down PHM into the high growth and low growth companies, multiplying the appropriate growth rates and then adding them together.
I don't know how I feel about the stock going into the 40 range. As soon as it hits 46 cents, the stock would be trading at the same price as the sleep management price paid plus the cash raised at the private placement. Making all of the other part of PHM essentially free after debt.
sleep management was 100M + 57M on hand after the deal. 157/335=0.46 cents.